Moreover, a study conducted in unrelated subjects of European descent revealed, HOXB13 G84E mutation was detected in 1.4% (72/5083) and 0.07% (1/1401) of participants with- and without prostate cancer, respectively (P<0.05) (213). Here, HOXB13 is linked to prostate cancer.